| Followers | 9 |
| Posts | 729 |
| Boards Moderated | 0 |
| Alias Born | 05/06/2014 |
Tuesday, October 13, 2020 10:46:32 AM
Yep, they changed the company name to QSAM Biosciences Inc from Q2Earth and before that Q2Power.
Q2Power had hired a few of the engineers from Ohio State University who had tried to fix the problems with the Cyclone WHE engine. They sold one system, took a down payment from the customer then laid off the engineers and vacated their rented building. The customer is still waiting for the system.
Then they were going to corner the market for compost and had licensed a patent and formula for some wonder compost. Instead of buckling down and doing the work to make compost, they sold paper to raise money to invest in compost companies. Of course all the money raised went to pay executive salaries, bonuses and consulting fees to insiders.
Now they have given up on compost and have latched onto a cancer drug. It's been flogged around since at least 2011 and nobody in the pharmaceutical industry would touch it. The Phase 1 clinical trial has been approved, and if they can get the money to fund it starting now, it will take until September 2023 to have the results. Best case scenario is they could then raise some more money for the Phase 2 clinical trial, then the Phase 3 clinical trial after that.
Meanwhile, the company has $4 million in notes that are currently in default. These will convert into stock which will be dumped onto the market. Just like Cyclone did.
Oh, and here's a photo of QSAM Biosciences Inc World Headquarters:
The company occupies one of the rented mailboxes inside.
Q2Power had hired a few of the engineers from Ohio State University who had tried to fix the problems with the Cyclone WHE engine. They sold one system, took a down payment from the customer then laid off the engineers and vacated their rented building. The customer is still waiting for the system.
Then they were going to corner the market for compost and had licensed a patent and formula for some wonder compost. Instead of buckling down and doing the work to make compost, they sold paper to raise money to invest in compost companies. Of course all the money raised went to pay executive salaries, bonuses and consulting fees to insiders.
Now they have given up on compost and have latched onto a cancer drug. It's been flogged around since at least 2011 and nobody in the pharmaceutical industry would touch it. The Phase 1 clinical trial has been approved, and if they can get the money to fund it starting now, it will take until September 2023 to have the results. Best case scenario is they could then raise some more money for the Phase 2 clinical trial, then the Phase 3 clinical trial after that.
Meanwhile, the company has $4 million in notes that are currently in default. These will convert into stock which will be dumped onto the market. Just like Cyclone did.
Oh, and here's a photo of QSAM Biosciences Inc World Headquarters:
The company occupies one of the rented mailboxes inside.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
